Skip to Main Content

Paper Details

The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.
Cell Rep
35
2019
AGR2, Breast Cancer, ER, FOXA1, GRHL2, LYPD3, LYPD3 ligand, breast cancer, coregulated target gene, estrogen, estrogen receptor, estrogen receptor-alpha, estrogen receptor-alpha (ER)-positive breast cancer, humanized, mice, mouse, transcription factors, tumors
Author NameAffiliation
Terry HyslopDuke Cancer Institute, Duke University School of Medicine
Gregory E CrawfordDuke University School of Medicine
Gregory E CrawfordDuke University School of Medicine
Myles BrownCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School
Donald P McDonnellDuke University School of Medicine
  • 1 - 5

Datasets

Release 1.2